论文部分内容阅读
急性心肌梗死(acute myocardial infarction,AMI)有发病率高、病情变化快、病死率高等特点[1-4]。早期再灌注治疗是治疗AMI最有效的方法,而且再灌注时间越早,疗效越好[1-5]。虽然随着经皮冠状动脉介入治疗技术的开展,AMI的预后有所改善,然而广大基层医院由于技术、设备等限制,仍以静脉溶栓为主,因此如何尽早开展溶栓就成了AMI治疗的关键。为提前
Acute myocardial infarction (AMI) has a high incidence, rapid changes in the disease, high mortality [1-4]. Early reperfusion therapy is the most effective treatment of AMI, and the earlier the reperfusion time, the better the efficacy [1-5]. Although with the development of percutaneous coronary interventional therapy, the prognosis of AMI has been improved. However, the majority of primary hospitals are still mainly treated with intravenous thrombolysis due to technical and equipment limitations. Therefore, how to carry out thrombolytic therapy as soon as possible has become the treatment of AMI key. In advance